Windlas Biotech Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech conducted a postal ballot (e-voting) that closed on March 19, 2026, for three special resolutions. All three were approved with near-unanimous support: 15,320,883 votes in favour (≈100%) and just 2 votes against each. The resolutions covered the re-appointment of Mr. Ashok Kumar Windlass as Whole-time Director, Mr. Vivek Dhariwal as Independent Director, and Mr. Gaurav Gulati as Independent Director, all effective from May 2026. Out of 21,077,239 total outstanding shares, 15,320,885 shares (72.69%) were voted. Promoter and promoter group were marked as interested in Resolution 1 since Mr. Ashok Kumar Windlass is a promoter. The scrutinizer (Sandeep Joshi, Practicing Company Secretary) confirmed the results.
The re-appointments were largely a formality — promoter and institutional support ensured passage with virtually no opposition. Investors should note continuity at the board level, with one promoter family member (Whole-time Director) and two independent directors retaining their positions. No material change to governance or shareholding is expected from this outcome.